Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
Publication
, Journal Article
Galadanci, NA; Abdullahi, SU; Ali Abubakar, S; Wudil Jibir, B; Aminu, H; Tijjani, A; Abba, MS; Tabari, MA; Galadanci, A; Borodo, AM; Belonwu, R ...
Published in: American journal of hematology
September 2020
Altmetric Attention Stats
Dimensions Citation Stats
Published In
American journal of hematology
DOI
EISSN
1096-8652
ISSN
0361-8609
Publication Date
September 2020
Volume
95
Issue
9
Start / End Page
E247 / E250
Related Subject Headings
- Stroke
- Nigeria
- Male
- Immunology
- Hydroxyurea
- Humans
- Female
- Child, Preschool
- Child
- Anemia, Sickle Cell
Citation
APA
Chicago
ICMJE
MLA
NLM
Galadanci, N. A., Abdullahi, S. U., Ali Abubakar, S., Wudil Jibir, B., Aminu, H., Tijjani, A., … DeBaun, M. R. (2020). Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. American Journal of Hematology, 95(9), E247–E250. https://doi.org/10.1002/ajh.25900
Galadanci, Najibah A., Shehu U. Abdullahi, Shehi Ali Abubakar, Binta Wudil Jibir, Hauwa Aminu, Aliyu Tijjani, Muhammad S. Abba, et al. “Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.” American Journal of Hematology 95, no. 9 (September 2020): E247–50. https://doi.org/10.1002/ajh.25900.
Galadanci NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, Aminu H, Tijjani A, et al. Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. American journal of hematology. 2020 Sep;95(9):E247–50.
Galadanci, Najibah A., et al. “Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.” American Journal of Hematology, vol. 95, no. 9, Sept. 2020, pp. E247–50. Epmc, doi:10.1002/ajh.25900.
Galadanci NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, Aminu H, Tijjani A, Abba MS, Tabari MA, Galadanci A, Borodo AM, Belonwu R, Salihu AS, Rodeghier M, Ghafuri DL, Covert C Greene BV, Neville K, Kassim AA, Kirkham FJ, Jordan LC, Aliyu MH, DeBaun MR. Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial. American journal of hematology. 2020 Sep;95(9):E247–E250.
Published In
American journal of hematology
DOI
EISSN
1096-8652
ISSN
0361-8609
Publication Date
September 2020
Volume
95
Issue
9
Start / End Page
E247 / E250
Related Subject Headings
- Stroke
- Nigeria
- Male
- Immunology
- Hydroxyurea
- Humans
- Female
- Child, Preschool
- Child
- Anemia, Sickle Cell